Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Found 123 results
Author
Title
Type
[
Year
]
Filters:
Filter
is
[Clear All Filters]
2019
Patel A
,
Namn Y
,
Shah SL
,
Scherl E
,
Wan DW
. 2019.
Takotsubo cardiomyopathy after an upper and lower endoscopy: a case report and review of the literature.
.
J Med Case Rep. 13(1):81.
Qazi T
,
Verma R
,
Hamilton MJ
,
Kaplan ER
,
Redline S
,
Burakoff R
. 2019.
The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
.
Inflamm Bowel Dis. 25(6):1044-1053.
Choi AJ
,
Atteberry P
,
Lukin DJ
. 2019.
Vaccination in the Elderly and IBD.
.
Curr Treat Options Gastroenterol. 17(4):492-505.
2018
Zhang S
,
Fu J
,
Dogan B
,
Scherl EJ
,
Simpson KW
. 2018.
5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
.
J Antibiot (Tokyo). 71(11):950-961.
Borges LF
,
Jagadeesan V
,
Goldberg H
,
Gavini S
,
Lo W-K
,
Burakoff R
,
Feldman N
,
Chan WW
. 2018.
Abnormal Bolus Reflux Is Associated With Poor Pulmonary Outcome in Patients With Idiopathic Pulmonary Fibrosis.
.
J Neurogastroenterol Motil. 24(3):395-402.
Dulai PS
,
Boland BS
,
Singh S
,
Chaudrey K
,
Koliani-Pace JL
,
Kochhar G
,
Parikh MP
,
Shmidt E
,
Hartke J
,
Chilukuri P
et al.
. 2018.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
.
Gastroenterology. 155(3):687-695.e10.
Dogan B
,
Belcher-Timme HFacey
,
Dogan EI
,
Jiang Z-D
,
Dupont HL
,
Snyder N
,
Yang S
,
Chandler B
,
Scherl EJ
,
Simpson KW
. 2018.
Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome.
.
FEMS Microbiol Lett. 365(22)
Kumar A
,
Kim M
,
Lukin DJ
. 2018.
Helicobacter pylori is associated with increased risk of serrated colonic polyps: Analysis of serrated polyp risk factors.
.
Indian J Gastroenterol. 37(3):235-242.
Cohen-Mekelburg S
,
Rosenblatt R
,
Gold S
,
Burakoff R
,
Waljee AK
,
Saini S
,
Schackman BR
,
Scherl E
,
Crawford C
. 2018.
The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients.
.
J Crohns Colitis. 12(9):1030-1035.
Castellanos JG
,
Woo V
,
Viladomiu M
,
Putzel G
,
Lima S
,
Diehl GE
,
Marderstein AR
,
Gandara J
,
Perez AR
,
Withers DR
et al.
. 2018.
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
.
Immunity. 49(6):1077-1089.e5.
Ghosh G
,
Jacob V
,
Wan D
. 2018.
Plasmablastic Lymphoma in a Patient With Crohn's Disease After Extensive Immunosuppressive Therapy.
.
Clin Gastroenterol Hepatol. 16(4):e41-e42.
Shmidt E
,
Kochhar G
,
Hartke J
,
Chilukuri P
,
Meserve J
,
Chaudrey K
,
Koliani-Pace JL
,
Hirten R
,
Faleck D
,
Barocas M
et al.
. 2018.
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
.
Inflamm Bowel Dis. 24(11):2461-2467.
Dogan B
,
Fu J
,
Zhang S
,
Scherl EJ
,
Simpson KW
. 2018.
Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses.
.
J Antibiot (Tokyo). 71(5):485-494.
Battat R
,
Duijvestein M
,
Casteele NVande
,
Singh S
,
Dulai PS
,
Valasek MA
,
Mimms L
,
McFarland J
,
Hester KD
,
Renshaw M
et al.
. 2018.
Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
.
Clin Gastroenterol Hepatol.
Cohen-Mekelburg S
,
Tafesh Z
,
Coburn E
,
Weg R
,
Malik N
,
Webb C
,
Hammad H
,
Scherl E
,
Bosworth BP
. 2018.
Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.
.
Dig Dis Sci. 63(9):2439-2444.
Gold SL
,
Magro C
,
Scherl E
. 2018.
A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease.
.
Gastroenterology. 155(4):981-982.
Narula N
,
Peerani F
,
Meserve J
,
Kochhar G
,
Chaudrey K
,
Hartke J
,
Chilukuri P
,
Koliani-Pace J
,
Winters A
,
Katta L
et al.
. 2018.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
.
Am J Gastroenterol. 113(9):1345.
2017
Battat R
,
Kopylov U
,
Bessissow T
,
Bitton A
,
Cohen A
,
Jain A
,
Martel M
,
Seidman E
,
Afif W
. 2017.
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease.
.
Clin Gastroenterol Hepatol. 15(9):1427-1434.e2.
Viladomiu M
,
Kivolowitz C
,
Abdulhamid A
,
Dogan B
,
Victorio D
,
Castellanos JG
,
Woo V
,
Teng F
,
Tran NL
,
Sczesnak A
et al.
. 2017.
IgA-coated enriched in Crohn's disease spondyloarthritis promote T17-dependent inflammation.
.
Sci Transl Med. 9(376)
J Blander M
,
Longman RS
,
Iliev ID
,
Sonnenberg GF
,
Artis D
. 2017.
Regulation of inflammation by microbiota interactions with the host.
.
Nat Immunol. 18(8):851-860.
Jacob V
,
Crawford C
,
Cohen-Mekelburg S
,
Viladomiu M
,
Putzel GG
,
Schneider Y
,
Chabouni F
,
OʼNeil S
,
Bosworth B
,
Woo V
et al.
. 2017.
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
.
Inflamm Bowel Dis. 23(6):903-911.
Battat R
,
Kopylov U
,
Byer J
,
Sewitch MJ
,
Rahme E
,
Nedjar H
,
Zelikovic E
,
Dionne S
,
Bessissow T
,
Afif W
et al.
. 2017.
Vitamin B12 deficiency in inflammatory bowel disease: a prospective observational pilot study.
.
Eur J Gastroenterol Hepatol. 29(12):1361-1367.
2016
DeFilippis EM
,
Longman R
,
Harbus M
,
Dannenberg K
,
Scherl EJ
. 2016.
Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.
.
Curr Gastroenterol Rep. 18(3):13.
DeFilippis EM
,
Tabani S
,
Warren RU
,
Christos PJ
,
Scherl EJ
. 2016.
Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease.
.
Dig Dis Sci. 61(1):215-20.
Kivolowitz C
,
Abdulhamid A
,
Victorio D
,
Castellanos J
,
Simpson K
,
Scherl E
,
Longman R
. 2016.
O-006 Expansion of Immunologically-Relevant E. Coli in the Intestinal Microbiota of Patients with IBD-Associated Spondyloarthritis Promotes Mucosal RORgt-Dependent Immunity.
.
Inflamm Bowel Dis. 22 Suppl 1:S3.
« first
‹ previous
1
2
3
(current)
4
5
next ›
last »